Aqua Bio Technology ASA (OSL:ABTEC)

Market Cap	71.64M
Revenue (ttm)	101.51M
Net Income (ttm)	-144.70M
Shares Out	159.38M
EPS (ttm)	-1.32
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	103,249
Average Volume	428,507
Open	0.4600
Previous Close	0.4600
Day's Range	0.4350 - 0.4600
52-Week Range	0.4250 - 3.9900
Beta	0.33
RSI	41.18
Earnings Date	Feb 27, 2026

About Aqua Bio Technology ASA

Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is based in Oslo, Norway.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 37
• Stock Exchange: Oslo Børs
• Ticker Symbol: ABTEC

Financial Performance

In 2024, Aqua Bio Technology ASA's revenue was 107.17 million, an increase of 472.00% compared to the previous year's 18.74 million. Losses were -337.35 million, 1504.6% more than in 2023.